Canopy Growth (CGC) Income towards Parent Company (2019 - 2025)

Canopy Growth (CGC) reported Income towards Parent Company of -$3.6 million for Q3 2025, down 251.5% on a YoY basis from $2.4 million in Q3 2024, and down 251.5% sequentially from $2.4 million in Q3 2024.

Canopy Growth (CGC) Income towards Parent Company (2019 - 2025) Analysis & Trends

Canopy Growth (CGC) has 7 years of Income towards Parent Company data on file, last reported at -$3.6 million in Q3 2025.

  • For the quarter ending Q3 2025, Income towards Parent Company fell 251.5% year-over-year to -$3.6 million; the trailing twelve-month figure through Mar 2026 stood at -$3.6 million (down 193.02% YoY), and the FY2025 full-year result was -$55.2 million, changed N/A from the prior year.
  • Income towards Parent Company retreated to -$3.6 million in Q3 2025, from $2.4 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $317.2 million in Q2 2021 to a low of -$1.6 billion in Q2 2022.
  • A 5-year average of -$138.9 million and a median of -$25.5 million in 2022 frame the typical range for Income towards Parent Company.
  • Across the five-year window, Income towards Parent Company soared 442.79% in 2021 and sank 617.16% in 2022, its largest moves.
  • Tracing CGC's Income towards Parent Company over 5 years: stood at -$91.6 million in 2021, then surged by 69.82% to -$27.6 million in 2022, then jumped by 135.81% to $9.9 million in 2023, then tumbled by 75.89% to $2.4 million in 2024, then sank by 251.5% to -$3.6 million in 2025.
  • Business Quant data shows CGC's Income towards Parent Company at -$3.6 million in Q3 2025, $2.4 million in Q3 2024, and $1.5 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Canopy Growth 276.52 Mn 10.60 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -3.62 Mn
Sep 30, 2024 2.39 Mn
Jun 30, 2024 1.50 Mn
Mar 31, 2024 1.74 Mn
Dec 31, 2023 9.90 Mn
Sep 30, 2023 -131.76 Mn
Jun 30, 2023 -23.30 Mn
Mar 31, 2023 -44.10 Mn
Dec 31, 2022 -27.65 Mn
Sep 30, 2022 -83.84 Mn
Jun 30, 2022 -1.64 Bn
Mar 31, 2022 -408.19 Mn
Dec 31, 2021 -91.63 Mn
Sep 30, 2021 -12.97 Mn
Jun 30, 2021 317.24 Mn
Mar 31, 2021 -87.57 Mn
Dec 31, 2020 -636.08 Mn
Sep 30, 2020 -72.45 Mn
Jun 30, 2020 -92.55 Mn
Mar 31, 2020 -1.09 Bn